Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac Involvement in Emery-Dreifuss Muscular Dystrophy, from Arrhythmias to Heart Failure and Sudden Death: A Contemporary Review.

Journal of clinical medicine·2026
Same author

Predictive value of early recurrence after atrial fibrillation ablation: A propensity-matched comparison between pulsed field ablation and radiofrequency ablation.

Heart rhythm·2026
Same author

Jugular Versus Femoral Venous Access for Leadless Pacemaker Implantation: A Systematic Review and Meta-Analysis.

Pacing and clinical electrophysiology : PACE·2026
Same author

Improved endothelial function in heart failure outpatients with reduced ejection fraction after vericiguat therapy.

Journal of cardiovascular medicine (Hagerstown, Md.)·2026
Same author

Long-term outcomes following sacubitril/valsartan therapy for chronic HFrEF: an Italian real-world multicentre study.

ESC heart failure·2026
Same author

Hypertrophic Cardiomyopathy Phenocopies: Classification, Key Features, and Differential Diagnosis.

Biomedicines·2025
Same journal

Clinical outcomes of intravascular imaging-guided versus angiography-guided drug-coated balloon angioplasty for de novo coronary lesions.

International journal of cardiology·2026
Same journal

Hypertension management in obstructive hypertrophic cardiomyopathy patients treated with cardiac myosin inhibitors - real world data.

International journal of cardiology·2026
Same journal

Fully quantitative CMR rest perfusion reveals myocardial perfusion abnormality in Kawasaki disease: Association with left ventricular Remodeling.

International journal of cardiology·2026
Same journal

Predicted adherence and ischaemic stroke risk in atrial fibrillation patients initiating oral anticoagulation: A cohort study of the medication adherence score.

International journal of cardiology·2026
Same journal

Severe tricuspid regurgitation is a congestion-driven cardiorenal disease: A longitudinal study defining a right heart failure phenotype.

International journal of cardiology·2026
Same journal

Applicability of ischemic heart disease clinical practice guidelines in low- and middle-income countries.

International journal of cardiology·2026
See all related articles

Related Experiment Video

Updated: Jun 23, 2026

An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

Hashitoxicosis with pericardial effusion.

Annalisa Lamari1, Giuseppe Dattilo2, Domenico Tulino3

  • 1Clinical and Experimental Department of Medicine and Pharmacology, University of Messina, Italy.

International Journal of Cardiology
|May 1, 2009
PubMed
Summary
This summary is machine-generated.

Subclinical thyroid dysfunction can harm the cardiovascular system. This case highlights pericardial effusion in subclinical hyperthyroidism (Hashitoxicosis), a rare but serious cardiac complication.

Related Experiment Videos

Last Updated: Jun 23, 2026

An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

Area of Science:

  • Endocrinology
  • Cardiology

Background:

  • Subclinical thyroid dysfunction, including subclinical hyperthyroidism and hypothyroidism, is linked to cardiovascular risks.
  • While subclinical hypothyroidism is associated with atherosclerosis and increased cardiovascular mortality, subclinical hyperthyroidism's cardiac impact is debated, though it may induce arrhythmias.

Observation:

  • Pericardial effusion is a rare manifestation of hyperthyroidism but can occur in hypothyroidism.
  • This study presents a unique case of pericardial effusion in a patient with subclinical hyperthyroidism during the hyperthyroid phase of chronic autoimmune thyreopathy (Hashitoxicosis).

Findings:

  • The case demonstrates that subclinical hyperthyroidism, though typically not linked to coronary heart disease, can manifest with significant cardiac complications like pericardial effusion.
  • This challenges the notion that subclinical hyperthyroidism is benign for cardiovascular health.

Implications:

  • This case underscores the importance of considering cardiac complications in subclinical hyperthyroidism, even in its early stages.
  • Further research is needed to fully elucidate the cardiovascular risks associated with subclinical thyroid dysfunction and guide clinical management.